Risk factor
Very poor trading liquidity
Profitability factor
Very favourable analyst view
About
EMVision Medical Devices Limited is an Australian enterprise specializing in the innovation, development, and market introduction of advanced imaging and diagnostic healthcare technologies. The company's principal offering is a compact, mobile brain scanner engineered for the swift detection and continuous tracking of strokes, in addition to fulfilling other medical imaging necessities. Founded in 2017, its operations are headquartered in Macquarie Park.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers.
Target Price
The average target price of EMV.AX is 3.15 and suggests 98.1% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in